Author details

Full Name

Alex H Ramos

Affiliation

ORCID

Career Start Year

2007

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
35351411	Differences and similarities in endothelial and angiogenic profiles of preeclampsia and COVID-19 in pregnancy.	American Journal of Obstetrics and Gynecology	2022
26710000	Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms.	Journal of Visualized Experiments	2015
25703262	Oncotator: cancer variant annotation tool.	Hum Mutat	2015
25058389	NAMPT is the cellular target of STF-31-like small-molecule probes.	ACS Chem Biol	2014
23334666	The genetic landscape of high-risk neuroblastoma.	Nat Genet	2013
23770567	Mutational heterogeneity in cancer and the search for new cancer-associated genes.	Nature	2013
24185511	Somatic mutation of CDKN1B in small intestine neuroendocrine tumors.	Nat Genet	2013
23525077	Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity.	Nat Genet	2013
23622249	Punctuated evolution of prostate cancer genomes.	Cell	2013
22817889	A landscape of driver mutations in melanoma.	Cell	2012
22751462	Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis.	Cancer Res	2012
22622578	Melanoma genome sequencing reveals frequent PREX2 mutations.	Nature	2012
22722202	Sequence analysis of mutations and translocations across breast cancer subtypes.	Nature	2012
22820256	Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations.	Nature	2012
22610119	Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer.	Nat Genet	2012
21798893	The mutational landscape of head and neck squamous cell carcinoma.	Science	2011
22328973	Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer.	Cancer Discov	2011
21307934	The genomic complexity of primary human prostate cancer.	Nature	2011
21430775	Initial genome sequencing and analysis of multiple myeloma.	Nature	2011
21892161	Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion.	Nat Genet	2011
21666749	Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancer.	PLoS One	2011
20601955	Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy.	Nat Genet	2010
19801978	SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas.	Nat Genet	2009
19755855	Amplification of chromosomal segment 4q12 in non-small cell lung cancer.	Cancer Biol Ther	2009
18701503	Focal gains of VEGFA and molecular classification of hepatocellular carcinoma.	Cancer Res	2008
18552176	Drug-sensitive FGFR2 mutations in endometrial carcinoma.	Proc Natl Acad Sci U S A	2008
18929564	Pivotal role of mTOR signaling in hepatocellular carcinoma.	Gastroenterology	2008
17982442	Characterizing the cancer genome in lung adenocarcinoma.	Nature	2007